Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Navamedic Director's Dealing 2021

Mar 26, 2021

3668_rns_2021-03-26_4ebad55d-5f7b-4217-9893-01413f488aec.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Notification of transactions by Primary Insiders and Close Associates

1 Details of the Primary Insider/Close Associate
a) Name Ingerø Reiten Investment Company AS
2 Reason for the notification
a) Position/status The notification concerns a legal person closely associated with a Primary
Insider: Narve Reiten, Board Member of Navamedic ASA.
b) Initial notification/
Amendment
Initial notification.
3 Details of Navamedic ASA, emission allowance market participant, auction platform, auctioneer or
auction monitor
a) Name Navamedic ASA
b) LEI 529900LKVQOR2SRUJU71
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type
of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial
instrument, type of
instrument
Identification code
Nature of the instrument: Shares
Instrument identification code (ISIN): NO0010205966
b) Nature of the transaction Pedging of shares.
Transaction is not linked to the exercise of a share option programme.
c) Price(s) and volume(s) Price(s) Volume(s)
0 3 563 042
Transaction currency in NOK.
d) Aggregated information Price: 0 NOK

Aggregated volume
Volume: 3 563 042 shares

Price
e) Date of the transaction 2021-03-26
f) Place of the transaction XOSL – Oslo Børs